TLC Ranks Top 5% Again in Corporate Governance Evaluations
08. Mai 2018 07:45 ET
|
Taiwan Liposome Company, Ltd.
TAIPEI, Taiwan, May 08, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization...
TLC Announces Application with U.S. FDA for Proceeding of TLC590 as Investigational New Drug (IND)
02. April 2018 18:59 ET
|
Taiwan Liposome Company, Ltd.
TAIPEI, Taiwan, April 03, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (“TLC”), a clinical-stage specialty pharmaceutical company dedicated to the development and...